Addus HomeCare’s (ADUS) Hold (C+) Rating Reiterated at Weiss Ratings

Weiss Ratings reaffirmed their hold (c+) rating on shares of Addus HomeCare (NASDAQ:ADUS) in a research note released on Wednesday,Weiss Ratings reports.

ADUS has been the topic of a number of other reports. TD Cowen upped their target price on shares of Addus HomeCare from $135.00 to $139.00 and gave the company a “buy” rating in a research report on Wednesday, August 6th. Wall Street Zen upgraded shares of Addus HomeCare from a “hold” rating to a “buy” rating in a research report on Sunday, June 29th. Macquarie restated an “outperform” rating and set a $133.00 target price on shares of Addus HomeCare in a research report on Tuesday, June 10th. Stephens restated an “overweight” rating and set a $140.00 target price on shares of Addus HomeCare in a research report on Wednesday, September 3rd. Finally, Barclays upped their target price on shares of Addus HomeCare from $83.00 to $109.00 and gave the company an “underweight” rating in a research report on Tuesday, August 19th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $137.50.

Addus HomeCare Stock Down 1.3%

Shares of NASDAQ ADUS opened at $112.91 on Wednesday. The firm’s 50-day simple moving average is $113.69 and its 200 day simple moving average is $109.90. The company has a market cap of $2.08 billion, a price-to-earnings ratio of 24.92, a price-to-earnings-growth ratio of 1.74 and a beta of 0.86. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.17. Addus HomeCare has a 12-month low of $88.96 and a 12-month high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, August 4th. The company reported $1.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.45 by $0.04. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.39%. The company had revenue of $349.44 million for the quarter, compared to the consensus estimate of $345.71 million. During the same period in the prior year, the company posted $1.35 EPS. The company’s revenue was up 21.8% compared to the same quarter last year. On average, research analysts expect that Addus HomeCare will post 4.59 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Addus HomeCare news, EVP Brian Poff sold 7,739 shares of the company’s stock in a transaction that occurred on Monday, August 25th. The stock was sold at an average price of $116.82, for a total transaction of $904,069.98. Following the completion of the transaction, the executive vice president owned 56,980 shares of the company’s stock, valued at $6,656,403.60. This represents a 11.96% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Veronica Hill-Milbourne sold 1,571 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $114.93, for a total value of $180,555.03. Following the transaction, the director directly owned 5,067 shares of the company’s stock, valued at approximately $582,350.31. This trade represents a 23.67% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 34,310 shares of company stock valued at $3,958,375. 4.50% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Addus HomeCare

Large investors have recently made changes to their positions in the stock. BI Asset Management Fondsmaeglerselskab A S acquired a new stake in shares of Addus HomeCare in the 1st quarter valued at approximately $41,000. State of Wyoming bought a new position in Addus HomeCare during the 2nd quarter worth $47,000. Raymond James Financial Inc. bought a new position in Addus HomeCare during the 2nd quarter worth $61,000. CWM LLC increased its position in Addus HomeCare by 25.3% during the 2nd quarter. CWM LLC now owns 554 shares of the company’s stock worth $64,000 after buying an additional 112 shares during the period. Finally, EverSource Wealth Advisors LLC increased its position in shares of Addus HomeCare by 560.0% in the second quarter. EverSource Wealth Advisors LLC now owns 561 shares of the company’s stock worth $65,000 after purchasing an additional 476 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.